AVCO   $0.5396  -14.35% Market Closed

Avalon GloboCare Corp
Last Events:

2023-03-29 Signal in EMA50 changed from bullish reversal to bearish reversal. The price is trying to cross down the moving average line If the intersection will be successful, then a downside trend can be formed.

2023-03-29 Signal in EMA50 changed from bearish reversal to bullish reversal. 2022-11-04 the price crossed up the moving average line and getting closer to the MA, which means that the short-term upside trend weakens.

2023-03-28 Signal in EMA50 changed from bullish reversal to bearish reversal. The price is trying to cross down the moving average line If the intersection will be successful, then a downside trend can be formed.

2023-03-28 Signal in EMA50 changed from bearish reversal to bullish reversal. 2022-11-04 the price crossed up the moving average line and getting closer to the MA, which means that the short-term upside trend weakens.

2023-03-27 Signal in EMA50 changed from bullish reversal to bearish reversal. The price is trying to cross down the moving average line If the intersection will be successful, then a downside trend can be formed.

2023-03-27 Signal in EMA50 changed from bearish reversal to bullish reversal. 2022-11-04 the price crossed up the moving average line and getting closer to the MA, which means that the short-term upside trend weakens.

2023-03-26 Signal in EMA50 changed from bullish reversal to bearish reversal. The price is trying to cross down the moving average line If the intersection will be successful, then a downside trend can be formed.

2023-03-26 Signal in EMA50 changed from bearish reversal to bullish reversal. 2022-11-04 the price crossed up the moving average line and getting closer to the MA, which means that the short-term upside trend weakens.


Current temperature: 4.42
ST: 0, Cor:

Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell Sell
rsi Sell Sell Sell
macd Sell Sell Sell
stoch Sell Sell Sell
ma20 - - -
ma50 - - -
ma100 - - -
Candlestick PatternOct. 31, 2022 Bullish Harami - consists of an unusually large black body followed by a small white body contained within large black body. It is considered as a bullish pattern when preceded by a downtrend.
ISIN US05344R1041
ceo Dr. David K. Jin M.D., Ph.D.
Website https://www.avalon-globocare.com
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and the People's Republic of China. The company offers medical related consulting services, including research studies, executive education, daily online executive briefings, tailored expert advisory services, and consulting and management services in the areas of immunotherapy and second opinion/referral services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells. It is also developing RNA-based FASH-CARTM cell therapy platform. In addition, the company develops avalon clinical-grade tissue-specific exosome (ACTEX); offers therapeutic and diagnostic targets utilizing QTY-code protein design technology with Massachusetts Institute of Technology (MIT), including using the QTY code protein design technology for development of a hemofiltration device to treat Cytokine Storm; and provides co-development of next generation, transposon-based, multi-target CAR-T, CAR-NK, and other immune effector cell therapeutic modalities with Arbele Limited. Further, it has strategic partnership with the University of Natural Resources and Life Sciences in Vienna and Austria to develop an S-layer vaccine that could be administered by an intranasal or oral route against SARS-CoV-2 and coronavirus that causes COVID-19 disease; and develops Avalon Cell and Avalon Rehab, as well as promotes standardization related to exosome industry. The company is headquartered in Freehold, New Jersey.